>>> US Early premarket gappers

Early premarket gappers
  • Gapping up:
    • OM +35.4%, TPC +22.8%, DUOL +22.2%, ALNT +22.2%, ARIS +21.6%, GRPN +20.9%, SKYT +20.4%, RUN +20.4%, NAGE +20.4%, ASLE +19.6%, MQ +19.5%, BROS +19.5%, CELH +18.5%, RELY +17.3%, MAX +13.5%, EBS +13.3%, UPWK +12.5%, ERII +12.3%, SRPT +12.1%, CRNC +12.1%, SPT +11.6%, MODG +11.5%, FSLY +11.3%, ECPG +10.9%, EVCM +10.5%, PBPB +9.8%, GFS +9.3%, DASH +9%, LFST +9%, AMPL +8.8%, BLBD +8.7%, CRH +8.6%, MIRM +8.6%, XNCR +8.4%, EHAB +7.8%, ROOT +7.3%, CXW +7.1%, EPAM +7.1%, HUBS +7%, ZD +7%, VEON +7%, DKNG +6.9%, HL +6.9%, IHG +6.7%, MKSI +6.5%, PAYC +6.2%, NNI +6%, GLW +5.7%, VCYT +5.5%, CIVI +5.5%, ACIW +5.5%, LUNR +5.2%, ROG +4.9%, OEC +4.9%, SITM +4.9%, BBSI +4.8%, NL +4.7%, DLX +4.4%, KLIC +4.3%, WTS +4.3%, SDGR +4.3%, VALN +4.2%, VRRM +4.2%, SONY +4.1%, CWAN +3.8%, APA +3.6%, AMAT +3.3%, AAPL +3.1%, ABSI +3.1%, SONO +3.1%, GPCR +3%, FG +3%, NSP +3%, RCUS +3%, HCC +3%, AIV +2.9%, TKO +2.8%, NNBR +2.8%, NLOP +2.7%, HP +2.6%, NATL +2.6%, TRGP +2.6%, PPTA +2.5%, CWST +2.4%, CTVA +2.4%, RVMD +2.3%, PRI +2.2%, SMHI +2.1%, ACAD +2.1%, TWFG +2%, RBA +2%, VECO +1.9%, ACDC +1.9%, ENOV +1.9%, DBRG +1.8%, FFAI +1.7%, LOPE +1.7%, CDE +1.6%, CACI +1.6%, OXY +1.6%, HAE +1.6%, CSGS +1.4%, SUZ +1.4%, FA +1.4%, ATO +1.3%, PR +1.3%, ECVT +1.3%, GLNG +1.2%, CPRX +1.1%, PRVA +1%
  • Gapping down:
    • RDW -23.4%, TNDM -20.4%, FTNT -20.1%, MNTK -15.9%, ATRO -15.7%, SYM -14.9%, EXAS -14.7%, COOK -14.7%, MLR -14.5%, SANA -12.7%, ADMA -11.7%, BMBL -10.7%, ELF -10.3%, ELDN -9.9%, HNST -8.4%, ABNB -6.6%, AOSL -6.5%, LNW -6.5%, POWI -6.4%, FSM -6.4%, FNF -6.3%, YETI -6.1%, NN -6%, JACK -5.8%, HIMX -5.6%, PDYN -5.2%, MET -5.2%, RAMP -4.8%, FSK -4.8%, GDRX -4.6%, IONQ -4.1%, JOBY -3.9%, CF -3.6%, MGNI -3.4%, ZLAB -3.2%, CDNA -3.1%, PBH -2.9%, XRAY -2.8%, SDRL -2.5%, FWRG -2.3%, DGII -2.2%, CRBG -2.1%, ET -2%, UGI -1.9%, BOW -1.8%, PTGX -1.8%, LYFT -1.8%, WPP -1.8%, SPCE -1.6%, RXO -1.5%, AIG -1.3%, TM -1.2%, MUR -1.1%

>>> Eli Lilly announces positive topline results from the Phase 3 ATTAIN-1 tria

Eli Lilly announces positive topline results from the Phase 3 ATTAIN-1 trial, evaluating orforglipron, an investigational oral glucagon-like peptide-1 receptor agonist, in 3,127 adults with obesity, or overweight with a weight-related medical problem and without diabetes (746.37)
  • In ATTAIN-1, the investigational once-daily oral pill showed significant efficacy, and a safety and tolerability profile consistent with injectable GLP-1 therapies at 72 weeks.
  • Orforglipron achieved the primary and all key secondary endpoints, including demonstrating improvements in a number of cardiovascular risk factors.
  • With these results, Lilly is on track to submit orforglipron to global regulatory agencies by year-end and is making substantial investments to meet anticipated demand at launch.

>>> Stoxx 600 Pre-Market Indications

  • Tomra (TMRA TH) +2.8%
    • Tomra Raised to Buy at Arctic Securities; PT 170 kroner
  • Rolls-Royce (RRU TH) +2.6%
  • KBC (KDB TH) +2%
    • KBC Boosts FY Net Interest Income Forecast
  • Neste (NEF TH) +1.7%
  • Evonik (EVK TH) +1.5%
  • Infineon (IFX TH) +1.5%
  • GEA Group (G1A TH) +1.3%
    • GEA Group 2Q Adjusted Ebitda Beats Estimates
  • Heineken (HNK1 TH) +1.3%
  • Stellantis (8TI TH) +1.2%
  • Zalando (ZAL TH) +1.1%
  • Leonardo (FMNB TH) -0.5%
  • TotalEnergies (TOTB TH) -0.5%
  • Carl Zeiss Meditec (AFX TH) -0.8%
    • Carl Zeiss Meditec 9M EPS EU1.02
  • RENK Group (R3NK TH) -0.8%
  • Shell (R6C0 TH) -0.9%
  • Roche (RHO5 TH) -1%
  • Carnival Plc (POH1 TH) -1.1%
  • Hensoldt (HAG TH) -1.3%
  • Rheinmetall (RHM TH) -2.1%
    • Rheinmetall 1H Operating Profit Misses Estimates
  • Equinor (DNQ TH) -2.3%

>>> TradeGate Pre-Market Indications

DAX:
  • Infineon (IFX TH) +1.9%
  • Zalando (ZAL TH) +1.4%
  • Siemens (SIE TH) +1.3%
    • *SIEMENS 3Q INDUSTRIAL BUSINESS PROFIT EU2.82B, EST. EU2.78B
  • Siemens Energy (ENR TH) +1.3%
    • Siemens Energy Rises on Order Beat, Strong Demand: Street Wrap
  • Continental (CON TH) +1%
  • Deutsche Telekom (DTE TH) -0.2%
    • Deutsche Telekom Raises 2025 Outlook on Strong US, Europe Sales
  • Rheinmetall (RHM TH) -1.3%
    • Rheinmetall 1H Operating Profit Misses Estimates
MDAX:
  • Evonik (EVK TH) +1.8%
    • Evonik Raised to Hold at Jefferies; PT 17.50 euros
  • GEA Group (G1A TH) +1.5%
    • GEA Group 2Q Adjusted Ebitda Beats Estimates
  • IONOS Group SE (IOS TH) +0.6%
    • IONOS Group SE 2Q Revenue Beats Estimates
SDAX:
  • Grenke (GLJ TH) +0.9%
  • Deutz (DEZ TH) +0.7%
    • Deutz 2Q Adjusted Ebit EU26.1M
  • GFT (GFT TH) -1.1%
  • SGL (SGL TH) -3.5%
    • SGL 1H Adjusted Ebitda EU72.5M Vs. EU86.5M Y/y

>>> Europe : Brokers Upgrades & Downgrades - 7th of August 2025

>>> Up
* AbbVie Raised to Outperform at Daiwa; PT $214
* Admicom Raised to Accumulate at Inderes; PT 55 euros
* AMD Raised to Hold at DZ Bank; PT $165(Earlier)
* Avolta Raised to Outperform at BNPP Exane; PT 51 Swiss francs
* Bank of Ireland Raised to Neutral at Mediobanca SpA
* BBVA Raised to Overweight at Barclays; PT 18 euros
* Cool Raised to Hold at Arctic Securities; PT 77 kroner
* Evonik Raised to Hold at Jefferies; PT 17.50 euros
* HKFoods Raised to Accumulate at Inderes; PT 1.70 euros
* HubSpot Raised to Overweight at Piper Sandler; PT $675
* Interpump Raised to Outperform at Mediobanca SpA; PT 45 euros
* Klaviyo Raised to Buy at Citi; PT $50
* Neste Raised to Outperform at BNPP Exane; PT 17 euros
* Stora Enso Raised to Equal-Weight at Barclays; PT 10.50 euros
* Tomra Raised to Buy at Arctic Securities; PT 170 kroner
* Uber Raised to Buy at Punto Casa de Bolsa; PT $105.64

>>> Down
* Airbnb Cut to Hold at Punto Casa de Bolsa; PT $138.36
* Caterpillar Cut to Underweight at Morgan Stanley; PT $350
* Comet Cut to Hold at Octavian; PT 220 Swiss francs
* Covestro Cut to Sell at Citi; PT 58 euros
* Marks & Spencer Cut to Reduce at AlphaValue/Baader
* Sampo Cut to Reduce at Inderes; PT 10 euros
* SSP Cut to Underperform at BNPP Exane; PT 160 pence
* Wacker Chemie Cut to Hold at Jefferies; PT 63 euros

>>> Initiation
* Siemens Energy ADRs Rated New Outperform at BNPP Exane; PT $136

>>> Call
* BP Upgraded to Buy at Berenberg as Strategy Boosts Cash Flow
* Fraport’s Cash Flow Visibility Improving, Jefferies Upgrades

>>> US Gapping up

Gapping up
In reaction to earnings/guidance:
  • MYGN +31.8%, CYRX +26.6%, FLYW +19.5%, GO +19.3%, ALAB +18.2%, RNG +15.2% (also names new CFO; also renewed collaboration with NICE), SHOP +15.2%, ANGI +14.9%, FTRE +14.6%, CRCT +14.2%, ANET +13%, HNGE +12.1%, KVYO +11.6%, LRN +11.3%, QDEL +10.9%, SKY +10.5%, DNOW +10.2%, CPRI +10.2%, PRCH +10.1%, GERN +10%, ZETA +9.5%, CURI +9.3%, TBLA +9%, HALO +8.9%, LEU +8.7%, WIX +8.7%, QLYS +8.3%, ATEN +7.6%, REZI +7.5%, CRL +7.5%, ADPT +6.7%, SGC +6.6%, DT +6.5%, GILT +6.4%, RVLV +6%, MTCH +6%, NYT +5.9%, ARDT +5.5%, BCO +5.5%, SSRM +5.2%, PCTY +5.2% (also share buyback auth increased by $500 mln), TRMB +5.2%, EXTR +5%, WWW +4.9%, CBLL +4.8%, IOSP +4.7%, IGIC +4.6%, GPN +4.6%, VVV +4.6%, IFF +4.5% (also to divest soy crush, concentrates & lecithin business; also authorizes new $500 mln share repurchase program), SUPN +4.3%, DV +4.2%, SWKS +3.9% (also increases dividend), NCMI +3.7% (also files for $300 mln mixed securities shelf offering), TDC +3.4%, ENLT +3.4%, MCD +3.3%, ACHC +3.1%, CRUS +3%, ONC +3%, OC +3%, VSH +3%, GEO +2.9%, CDW +2.9%, CG +2.8%, NAMS +2.6%, JELD +2.4%, LMAT +2.2%, HMC +2%, ODP +2%, DEI +1.9%, RIGL +1.8%, DBD +1.7%, DAY +1.6%, AFG +1.5%, BWIN +1.5%, IRM +1.5%, SAFE +1.4%, OUT +1.1%, SPR +1.1%, ITUB +1.1%, INSW +1.1%, BL +1% (also Therese Tucker, Co-CEO and Founder, to transition from her role as Co-CEO; Owen Ryan, currently Co-CEO and Chairman, will continue as sole CEO), MIDD +1%, CHH +0.9%
Other news:
  • CIX +7% (declares special div of $1/sh)
  • MDXH +4.4% (MDXH to acquire Exosome Diagnostics from TECH)
  • IONQ +2.8% (AMZN discloses new position in IONQ)
  • SPWH +2.3% (names new CFO)
  • JANX +2% (announces dosing of first patient in its TRACTr collaboration with Merck)
  • ICFI +1.9% (launches ICF Fathom, a new suite of AI offerings for federal agencies)
Analyst comments:
  • DRVN +3% (upgraded to Overweight from Neutral at JPMorgan)
  • HOLX +2.5% (upgraded to Outperform from Sector Perform at RBC Capital)
  • MNDY +1.7% (upgraded to Outperform from Neutral at Robert Baird)
  • KMX +1.2% (upgraded to Neutral from Underweight at JPMorgan)
  • INCY +1.2% (upgraded to Overweight from Equal Weight at Wells Fargo)
  • AFYA +1% (upgraded to Overweight from Underweight at Morgan Stanley)
  • BRBR +0.8% (upgraded to Overweight from Equal Weight at Stephens)
  • VRTX +0.8% (upgraded to Overweight from Equal Weight at Wells Fargo)

>>> Uber reports EPS in-line, beats on revs; provides Q3 guidance; New share rep

Uber reports EPS in-line, beats on revs; provides Q3 guidance; New share repurchase program authorized up to an additional $20 billion of common stock (89.39 0.96)
  • Reports Q2 (Jun) earnings of $0.63 per share, in-line with the FactSet Consensus of $0.63; revenues rose 18.2% year/year to $12.65 bln vs the $12.47 bln FactSet Consensus.
  • Gross Bookings grew 17% YoY to $46.8 billion, or 18% on a constant currency basis.
  • Adjusted EBITDA grew 35% YoY to $2.1 billion. Adjusted EBITDA margin as a percentage of Gross Bookings was 4.5%, up from 3.9% in Q2 2024.
  • Guidance: "For Q3 2025, we anticipate: Gross Bookings of $48.25 billion to $49.75 billion, representing growth of 17% to 21% YoY on a constant currency basis. Our outlook assumes a neutral to modestly positive FX impact to total reported YoY growth. As a reminder, our outlook includes the contribution from the close of the Trendyol Go acquisition; excluding this, our growth outlook would be 16% to 20% YoY on a constant-currency basis (consistent with the prior quarter). Adjusted EBITDA of $2.19 billion to $2.29 billion, which represents 30% to 36% YoY growth."
  • New share repurchase program authorized up to an additional $20 billion of common stock.

>>> US apri Holdings beats by $0.38, beats on revs; guides Q2 EPS below consensu

apri Holdings beats by $0.38, beats on revs; guides Q2 EPS below consensus, revs above consensus; guides FY26 EPS in-line, revs above consensus (18.20 -0.11)
  • Reports Q1 (Jun) earnings of $0.50 per share, excluding non-recurring items, $0.38 better than the FactSet Consensus of $0.12; revenues fell 6.0% year/year to $797 mln vs the $772.61 mln FactSet Consensus.
  • "We are encouraged by our first quarter results. Trends improved sequentially leading to both revenue and earnings per share that exceeded our expectations."...
  • Co issues mixed guidance for Q2, sees EPS of ~$0.10-0.15 vs. $0.28 FactSet Consensus; sees Q2 revs of ~$815-835 mln vs. $798.68 mln FactSet Consensus.
    • For Michael Kors, the Company expects the following:
      • Total revenue of approximately $685 to $700 million
      • Operating margin in the high-single-digit range
    • For Jimmy Choo, the Company expects the following:
      • Total revenue of approximately $130 to $135 million
      • Operating margin in the negative mid-single-digit range.
  • Co issues guidance for FY26, sees EPS of $1.20-1.40 vs. $1.26 FactSet Consensus; sees FY26 revs of $3.375-3.450 bln vs. $3.36 bln FactSet Consensus.
    • For Michael Kors, the Company expects the following:
      • Total revenue of approximately $2.8 to $2.875 billion
      • Operating margin in the high-single-digit range
    • For Jimmy Choo, the Company expects the following:
      • Total revenue of approximately $565 to $575 million
      • Operating margin in the negative mid-single-digit range.
  • Guidance reflects incremental tariffs on imports into the United States from the European Union at 15%, Cambodia and Indonesia at 19%, Bangladesh and Vietnam at 20%, India at 25% and China at 30%.